Financial Performance - The company's revenue for Q1 2022 was ¥161,564,904.21, representing an increase of 11.61% compared to ¥144,758,061.73 in the same period last year[4] - Net profit attributable to shareholders decreased by 75.20% to ¥6,298,759.91 from ¥25,397,680.57 year-on-year[4] - The company's basic earnings per share decreased by 71.43% to ¥0.02 from ¥0.07 in the same period last year[4] - The operating profit for Q1 2022 was CNY 7,446,179.80, down 75.2% from CNY 29,978,609.81 in the previous year[21] - The net profit for Q1 2022 was CNY 6,298,759.91, a decrease of 75.2% from CNY 25,397,680.57 in Q1 2021[21] Cash Flow - The net cash flow from operating activities improved by 34.67%, reaching -¥36,640,674.50 compared to -¥56,085,877.41 in the previous year[4] - Cash inflow from operating activities in Q1 2022 was CNY 179,984,641.31, significantly higher than CNY 87,101,283.60 in the same period last year[23] - The cash outflow from operating activities amounted to 216,625,315.81 CNY, an increase from 143,187,161.01 CNY year-over-year[25] - The ending balance of cash and cash equivalents was 1,009,330,737.93 CNY, up from 125,419,600.77 CNY year-over-year[26] - The company reported a total cash outflow from financing activities of 262,608.33 CNY, compared to 10,015,000.00 CNY in the previous year[25] Assets and Liabilities - Total assets increased by 122.15% to ¥1,741,864,954.53 from ¥784,090,343.65 at the end of the previous year[4] - The total liabilities as of Q1 2022 amounted to CNY 179,496,929.37, compared to CNY 130,021,302.75 in Q1 2021, reflecting a 38.0% increase[20] - The company's equity attributable to shareholders rose by 138.87% to ¥1,562,368,025.16 from ¥654,069,040.90 at the end of the previous year[4] Operating Costs and Expenses - The gross profit margin was impacted by rising raw material costs, particularly potassium chloride, leading to a 41% increase in operating costs to ¥142,865,303.12 from ¥101,391,449.60[8] - The total operating costs for Q1 2022 were CNY 154,953,925.02, up 31.4% from CNY 117,949,815.69 in Q1 2021[20] - Research and development expenses increased by 31% to ¥2,448,279.85 from ¥1,874,167.19 year-on-year[8] - Research and development expenses for Q1 2022 were CNY 2,448,279.85, an increase from CNY 1,874,167.19 in Q1 2021[20] Borrowings and Financing - The company reported a significant increase in short-term borrowings by 169% to ¥20,670,866.66 from ¥7,674,748.24 year-on-year[7] - Short-term borrowings increased to approximately 20.67 million RMB from 7.67 million RMB at the beginning of the year[17] - Total cash inflow from financing activities reached 921,040,401.00 CNY, with a net cash flow of 920,777,792.67 CNY, a significant increase from -10,015,000.00 CNY in the previous year[25] Market and Strategic Focus - The company plans to increase export business due to high overseas demand for potassium hydroxide, with significant growth in export orders expected[14] - The company aims to enhance the supply of potassium fertilizers, particularly during the spring planting season, leveraging its position in Sichuan[14] - The company is focusing on maintaining product quality to meet the demands of high-end clients in various sectors[14] - The company is enhancing its self-operated hazardous chemical transportation capacity to mitigate logistics challenges[14] Government Support - The company received government subsidies amounting to ¥464,504.95, a decrease of 86% compared to the previous year[8] Foreign Exchange Impact - The company experienced a foreign exchange impact of -79,673.99 CNY on cash and cash equivalents[25] Audit Status - The company did not conduct an audit for the first quarter report[27]
华融化学(301256) - 2022 Q1 - 季度财报